Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 11, 2005, Pages 4062-4071

  Zhang, Zhihong ^a,b   Ma, Jian Xing ^b,c   Gao, Guoquan ^b   Li, Chaoyang ^a,b   Luo, Lihui ^a,b   Zhang, Mei ^a,b   Yang, Wenzhao ^a,b   Jiang, Aihua ^a,b   Kuang, Wenhui ^a,b   Xu, Liying ^a,b   Chen, Jiaqi ^a,b   Liu, Zuguo ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; ANGIOGENESIS INHIBITOR; EYE DROPS; PLASMINOGEN KRINGLE 5; SODIUM HYDROXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; PEPTIDE FRAGMENT; PLASMINOGEN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; CATTLE; CAUSTIC BURN; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA BURN; CORNEA NEOVASCULARIZATION; DNA DAMAGE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; APOPTOSIS; CHEMICAL BURN; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; EYE BURN; METABOLISM; PATHOLOGY; TOPICAL DRUG ADMINISTRATION; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADMINISTRATION, TOPICAL; ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BURNS, CHEMICAL; CATTLE; CELL PROLIFERATION; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; EYE BURNS; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; PEPTIDE FRAGMENTS; PLASMINOGEN; RABBITS; SODIUM HYDROXIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33644686284     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1330     Document Type: Article

References (39)

1. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
2. Stoltz RA, Conners MS, Gerritsen ME, Abraham NG, Laniado-Schwartzman M. Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid. Am J Pathol. 1996;148:129-139.
3. Kaminska G, Niederkorn J. Spontaneous corneal neovascularization in nude mice: local imbalance between angiogenic and antiangiogenic factors. Invest Ophthalmol Vis Sci. 1993;34:222-230.
4. Kenyon B, Voest E, Chen C, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci. 1996;37:1625-1632.
5. Cursiefen C, Küchle M, Naumann GOH. Angiogenesis in corneal diseases: histopathology of 254 human corneal buttons with neovascularization. Cornea. 1998;17:611-613.
6. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45:2666-2673.
7. Casey R, Li WW. Factors controlling ocular angiogenesis. Am J Ophthalmol. 1997;124:521-529.
8. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43:245-209.
9. Singh N, Amin S, Richter E, et al. Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. Invest Ophthalmol Vis Sci. 2005;46:1647-1652.
10. Poulaki V, Mitsiades N, Kruse FE, et al. Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression. Am J Pathol. 2004;164:1293-1302.
11. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245-248.
12. Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol,. 2001;12:242-249.
13. Miller J. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol. 1997;151:13-23.
14. Zhang P, Wu D, Ge J, et al. Experimental inhibition of corneal neovascularization by endostatin gene transfection in vivo. Clin Med J. 2003;116:1869-1874.
15. Phillips GD, Stone AM, Jones BD, Schultz JC, Whitehead RA, Knighton DR. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo. 1994;8:961-965.
16. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in wound-and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22.
17. Cao Y, Chen A, An SS, et al. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem. 1997;272:22924-22928.
18. Cao Y, Ji RW, Davidson D, et al. Kringle 5 domains of human angiostatin: characterization of the anti-proliferative activity on endothelial cells. J Biol Chem. 1996;271:29461-29467.
19. Castellino FJ, McCance SG. The kringle domains of human plasminogen. Ciba Found Symp. 1997;212:46-65.
20. Ji WR, Barrientos LG, Llinas M, et al. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun. 1998;247:414-419.
21. Zhang D, Kaufman PL, Gao G, Saunders RA, Ma JX. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Diabetologia. 2001;44:757-765.
22. Ormerod LD, Abelson MB, Kenyon KR. Standard models of corneal injury using alkali-immersed filter discs. Invest Ophthalmol Vis Sci. 1989;30:2148-2153.
23. D'Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA. 1994;91:4082-4085.
24. Laria C, Alio JL, Ruiz-Moreno JM. Combined non-steroidal therapy in experimental corneal injury. Ophthalmic Res. 1997;29:145-153.
25. Sterpetti AV, Cucina A, Santoro-D'Angelo L, Cardillo B, Cavallaro A. Shear stress modulates the proliferation rate, protein synthesis, and mitogenic activity of arterial smooth muscle cells. Surgery. 1993;113:691-699.
26. Nicosia RF, Villaschi S, Smith M. Isolation and characterization of vasoformative endothelial cells from the rat aorta. In Vitro Cell Dev Biol Anim. 1994;30:394-399.
27. Villablanca AC, Reid TW. Substance P stimulates vascular endothelial cellular reducing capacity in the presence of insulin and human plasma factors. J Cell Biochem. 1997;66:471-481.
28. Lizard G, Deckert V, Dubrez L, Moisant M, Gambert P, Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am J Pathol. 1996;148:1625-1638.
29. Gohto Y, Obana A, Kaneda K, et al. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization. Exp Eye Res. 1998;67:313-322.
30. Murthy RC, McFarland TJ, Yoken J, et al. Corneal transduction to inhibit angiogenesis and graft failure. Invest Ophthalmol Vis Sci. 2003;44:1837-1842.
31. Ma X, Ottino P, Bazan HE, Bazan NG. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Invest Ophthalmol Vis Sci. 2004;45:2915-2921.
32. Ambati BK, Joussen AM, Ambati J, et al. Angiostatin inhibits and regresses corneal neovascularization. Arch Ophthalmol. 2002;120:1063-1068.
33. Mastyugin V, Mosaed S, Bonazzi A, Dunn MW, Schwartzman ML. Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear. Curr Eye Res. 2001;23:1-10.
34. Aiello LP. Vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1997;38:1647-1652.
35. Yoshida S, Yoshida A, Matsui H, Takada Y, Ishibashi T. Involvement of macrophage chemotactic protein-1 and interleukin-1beta during inflammatory but not basic fibroblast growth factor-dependent neovascularization in the mouse cornea. Lab Invest. 2003;83:927-938.
36. Guoquan G, Yan L, Stephen G, et al. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor. J Biol Chem,. 2002;277:9492-9497.
37. Gonzalez-Gronow M, Kalfa T, Johnson CE, Gawdi G, Pizzo SV. The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells. J Biol Chem. 2003;278:27312-27318.
38. Lu H, Dhanabal M, Volk R, et al. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells. Biochem Biophys Res Commun. 1999;258:668-673.
39. King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol. 1998;60:601-617.